Boehringer Ingelheim

In 2004, Evotec entered into a multi-year drug discovery collaboration with Boehringer Ingelheim to jointly identify and develop preclinical development candidates for the treatment of various diseases. The agreement has been expanded and extended on two occasions since its initiation. Under the terms of the agreement, Boehringer Ingelheim has full ownership and global responsibility for clinical development, manufacturing and commercialization of the compounds identified. In return, Evotec receives ongoing research payments, preclinical milestones. Furthermore, the contract provides a substantial long-term benefit for Evotec through potential payments for successful milestone achievements during clinical development and royalties when new drugs reach the market.

To date 15 milestones have been achieved as part of this agreement

11 January 2012
Evotec receives 4th Milestone Payment in 2011 as Part of its Discovery Alliance with Boehringer Ingelheim

18 August 2011
Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim

31 May 2011
Evotec receives Milestone as Boehringer Ingelheim starts Phase I clinical trial in Pain

9 May 2011
Twelfth Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim received

13 Jan 2011
Milestone Payment received from Boehringer Ingelheim

4 Aug 2010
Evotec Receives a Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim

17 June 2010
Evotec Earns Milestone in Oncology Programme as Part of its Research Alliance with Boehringer Ingelheim

19 May 2010
Evotec Brings Project in Neuropathic Pain into Clinical Development in its Alliance with Boehringer Ingelheim

9 Nov 2009
Evotec and Boehringer Ingelheim Extend and Broaden Research Collaboration

22 Oct 2009
Evotec Receives a EUR 2.5 Million Milestone Payment in its Research Collaboration with Boehringer Ingelheim

29 Jul 2009
Evotec Receives Milestone Payment from Boehringer Ingelheim

30 Oct 2008
Evotec Earns Two Milestone Payments from Boehringer Ingelheim

02 Sep 2008
Evotec and Boehringer Ingelheim Achieve Milestone in Joint Discovery Collaboration

19 Mar 2007
Evotec and Boehringer Ingelheim Enter into Target Discovery Collaboration in Alzheimer's Disease